Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion type Assertion NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_head.
- NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion description "[Upregulation of the EGF-R by integrin alphavbeta3, both receptor molecules with a well-defined role as targets for cancer treatment, might represent an additional mechanism to adapt synergistic receptor signaling and crosstalk in response to an altered tumor cell microenvironment during ovarian cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_provenance.
- NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion evidence source_evidence_literature NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_provenance.
- NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion SIO_000772 18577466 NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_provenance.
- NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion wasDerivedFrom befree-20150227 NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_provenance.
- NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_assertion wasGeneratedBy ECO_0000203 NP517342.RAUsPYYJ-2QWRiMDkQ8g-XJ-skClHslhBxpd2aLgT0mM0130_provenance.